The UK government said it would ask doctors treating critically ill COVID-19 patients in hospital intensive care units to begin using the drugs immediately. He said the drugs would be "crucial for helping to relieve pressure on intensive care and hospitals and saving lives". The United States has also authorised emergency use of some antibody drugs for non-hospitalised COVID-19 patients. Sanofi said in September that Kevzara - which it produces with partner Regeneron - failed to meet the main goals of a US study testing it in critically ill COVID-19 patients. "A crucial difference may be that in our study, critically ill patients were enrolled within 24 hours of starting organ support," he said.

Source: bd News24 January 07, 2021 16:52 UTC